Insulin resistance, hyperinsulinemia, and blood pressure: Role of age and obesity

Hypertension

Volumn 30, Issue 5, 1997, Pages 1144-1149

  Ferrannini, Ele ^a   Natali, Andrea ^b   Capaldo, Bruoella ^b   Lehtovirta, Mikko ^b   Jacob, Stefan ^b   Yki Järvinen, Hannele ^b  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b NONE

Author keywords

Arterial blood pressure; Insulin; Insulin action; Insulin resistance; Obesity

Indexed keywords

ADULT; AGED; AGING; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE MONITORING; FEMALE; GLUCOSE TOLERANCE; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; OBESITY; POPULATION RESEARCH; PRIORITY JOURNAL; SODIUM ABSORPTION;

EID: 0030680265     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.5.1144     Document Type: Article

References (38)

1. Welborn T, Brekenridge A, Rubistein A, Dollery C, Fraser T. Serum-insulin in essential hypertension and in peripheral vascular disease. Lancet. 1966;I:1336-1337.
2. Cederholm J, Wibell L. Glucose intolerance in middle-aged subjects a cause of hypertension. Acta Med Scand. 1985;217: 363-371.
3. Christlieb A, Krowleski A, Warram J, Soeldner J. Is insulin the Jink between hypertension and obesity? Hypertension. 1985;7(suppl II): 54-57.
4. Haffner S, Fong D, Hazuda H, Pugh J, Patterson J. Hyperinsulinemia, upper body adiposity, and cardiovascular risk factors in non-diabetics. Metabolism. 1988;37:338-345.
5. Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, Shitrit A, Fuchs Z. Hyperinsulinemia: a link between hypertension obesity and glucose intolerance. J Clin Invest. 1985;75:809-817.
6. Eriksson KF, Lindgarde F. Contribution of estimated insulin resistance and glucose intolerance to essential hypertension. J Int Med. 1991;229:75-83.
7. Denker PS, Pollok VE. Fasting serum insulin levels in essential hypertension. A meta analysis. Arch Intern Med. 1992;152: 1649-1651.
8. Bao W, Srinivasan S, Berenson G. Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults. Circulation. 1996;93:54-59.
9. Haffner S, Ferrannini E, Hazuda H, Stern M. Clustering of cardiovascular risk factors in confirmed prehypertensive individuals. Hypertension. 1992;20:38-45.
10. Fournier A, Gadia M, Kubrusly D, Skyler J, Sosenko J. Blood pressure, insulin, and glycemia in non diabetic subjects. Am J Med. 1986;80:861-864.
11. Jarrett R. Re: Hyperinsulinemia and elevated blood pressure: cause, confounder, or coincidence? Am J Epidemiol. 1991;134: 327-328.
12. Mbanya J-C, Wilkinson R, Thomas T, Albcrti K, Taylor R. Hypertension and hyperinsulinemia: a relation in diabetes but not in essential hypertension. Lancet. 1988;I:733-734.
13. Donhaue RP, Skyler JS, Sneiderman N, Prineas RJ. Hyperinsulinemia and elevated blood pressure: cause, confounder, or coincidence? Am J Epidemiol. 1990;132:827-836.
14. Jarrett R. In defence of insulin: a critique of syndrome X. Lancet. 1992;340:469-471.
15. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med. 1987;317: 350-357.
16. Pollare T, Lithell H, Berne C. Insulin resistance is a characteristic of primary hypertension independent of obesity. Metabolism. 1990; 39:167-174.
17. Laakso M, Sarlund H, Mykkanen L. Essential hypertension and insulin resistance in non-insulin-dependent diabetes. Eur J Clin Invest. 1989;19:518-526.
18. Natali A, Quiñones Galvan A, Santoro D, Pecori N, Taddei S, Salvetti A, Ferrannini E. Relationship between insulin release, antinatriuresis and hypokalemia after glucose ingestion in normal and hypertensive man. Clin Sci. 1993;85:327-335.
19. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest. 1991;87:2246-2252.
20. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173-194.
21. Office guide to diagnosis and classification of diabetes mellitus and other categories of glucose intolerance. Diabetes Care. 1995;8(suppl 1):4-7.
22. The fifth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure (JNC V). Arch Intern Med. 1993;153:154-183.
23. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214-E223.
24. Fink R, Kolterman O, Griffin J, Olefsky J. Mechanisms of insulin resistance in ageing. J Clin Invest. 1983;71:1523-1535.
25. Del Prato S, Ferrannini E, DeFronzo RA. Evaluation of insulin sensitivity in man. In: Clark WL, Larner J, Pohl SL, eds. Methods in Diabetes Research. New York: John Wiley and Sons; 1986:36-76.
26. Saad M, Lillioja S, Nyomba B, Castillo C, Ferraro R, DeGregorio M, Ravussin E, Knowler W, Bennett P, Howard B, Bogardus C. Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med. 1991;324:733-739.
27. National high blood pressure education program working group report on primary prevention of hypertension. Arch Intern Med. 1993;153:186-208.
28. Collins R, Peto R, MacMahon S, Hebert P, Fiebach N, Eberlein K, Godwin J, Qizilbash N, Taylor J, Hennekcns C. Blood pressure, stroke, and coronary artery disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335:827-838.
29. Lind L, Lithell H, Pollare T. Is it hyperinsulinemia or insulin resistance that is related to hypertension and other metabolic cardiovascular risk factors? J Hypertens. 1993;11(suppl 4):S11-S16.
30. Ferrannini E. The phenomenon of insulin resistance: its possible relevance to hypertensive disease. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management. New York: Raven Press; 1995:2281-2300.
31. Messerli F, Sundgaard-Riise K, Reisin E, Dreslinski G, Dunn F, Frohlich E. Disparate cardiovascular effects of obesity and arterial hypertension. Am J Med. 1983;74:808-812.
32. Reisin E, Frohlich E, Messerli F, Dreslinski G, Dunn F, Jones M. Cardiovascular changes after weight reduction in obesity hypertension. Ann Intern Med. 1983;98:315-319.
33. Rocchini AP, Katch V, Kveselis D, Moorehead C, Martin M, Lampman R, Gregory M. Insulin and renal sodium retention in obese adolescents. Hypertension. 1989;14:367-374.
34. Muscelli E, Natali A, Bianchi S, Bigazzi R, Quiñones Galvan A, Sironi AM, Frascerra S, Ciociaro D, Ferrannini E. Effect of insulin on renal sodium and uric acid handling in essential hypertension. Am J Hypertens. 1996;9:34-39.
35. Wollenweider P, Randin D, Tappy E, Jequier E, Nicod P, Seherrer U. Impaired insulin-induced sympathetic neural activation and vasodilatation in skeletal muscle in obese humans. J Clin Invest. 1994;93:2365-2371.
36. Steinberg H, Breehtel G, Johnson A, Fineberg N, Baron A. Insulin-mediated skeletal muscle vasodilatation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest. 1994;94:1172-1179.
37. Baron AD, Breehtel G. Insulin differentially regulates systemic and skeletal muscle vascular resistance. Am J Physiol. 1993;265: E61-E67.
38. Baron AD, Brechtel-Hook G, Johnson A, Hardin D. Skeletal muscle blood flow. A possible link between insulin resistance and blood pressure. Hypertension. 1993;21:129-135.